Security key
10919W405
BRIGHT MINDS BIOSCIENCES INC. - Common Shares, no par value (DRUG)
CUSIP: 10919W405
Q3 2023 13F Holders as of 30 Sep 2023
- Type / Class
- Equity / Common Shares, no par value
- Shares outstanding
- 9,846,380
- Total 13F shares
- 194,505
- Share change
- +194,505
- Total reported value
- $309,171
- Price per share
- $1.60
- Number of holders
- 5
- Value change
- +$309,171
- Number of buys
- 5
Report period
Q3 2023
Institutions
5
Top holders
5
DRUG full security history
Newer quarter: Q4 2023
BRIGHT MINDS BIOSCIENCES INC. SEC filings
BRIGHT MINDS BIOSCIENCES INC. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 10919W405
Recent filing periods:
Top shareholders of DRUG - BRIGHT MINDS BIOSCIENCES INC. - Common Shares, no par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| AdvisorShares Investments LLC |
13F
|
Company |
—
class O/S missing
|
515,315
|
$293,781 | — | 30 Jun 2023 | |
| TWO SIGMA SECURITIES, LLC |
13F
|
Company |
—
class O/S missing
|
16,723
|
$9,534 | — | 30 Jun 2023 | |
| Checchi Capital Advisers, LLC |
13F
|
Company |
—
class O/S missing
|
14,138
|
$8,060 | — | 30 Jun 2023 | |
| BlackRock Finance, Inc. |
13F
|
Company |
—
class O/S missing
|
11,801
|
$6,728 | — | 30 Jun 2023 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
—
class O/S missing
|
11,200
|
$6,000 | — | 30 Jun 2023 | |
| UBS Group AG |
13F
|
Company |
—
class O/S missing
|
2,098
|
$1,196 | — | 30 Jun 2023 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
—
class O/S missing
|
1,554
|
$1,000 | — | 30 Jun 2023 |
Institutional Holders of BRIGHT MINDS BIOSCIENCES INC. - Common Shares, no par value (DRUG) as of Q3 2023
As of 30 Sep 2023,
BRIGHT MINDS BIOSCIENCES INC. - Common Shares, no par value (DRUG) was held by
5 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
194,505 shares.
The largest 5 holders included
AdvisorShares Investments LLC, HRT FINANCIAL LP, Virtu Financial LLC, Aspire Private Capital, LLC, and BlackRock Inc..
This page lists
5
institutional shareholders reporting positions in this security
for the Q3 2023 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2023 vs Q4 2025 Across Filers
Q4 2025 holders
74
Q3 2023 holders
5
Holder diff
-69
| Investor | Q4 2025 Shares | Q3 2023 Shares | Share Diff | Share Chg % | Q4 2025 Value $ | Q3 2023 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.